Table 2 Cox multivariate regression analysis of disease-free survival, cancer-specific survival, and overall survival correlation of tumor deposits

TDs

0.571 (0.353–0.923)

0.022

0.464 (0.302–0.713)

0.000

0.538 (0.356–0.814)

0.003

Age, years

–

–

–

–

0.638 (1.089–2.462)

0.018

Histologic grade

–

–

1.040 (0.444–2.433)

0.929

1.198 (0.540–2.659)

0.657

Lauren classification

–

–

0.610

0.446

 Lauren (1)

0.668 (0.268–1.663)

0.385

0.579 (0.248–

0.207

 Lauren (2)

0.863 (0.311–2.399)

0.778

1.354)

0.688 (0.264–1.792)

0.444

LVI

0.549 (0.207–1.454)

0.228

0.960 (0.392–2.348)

0.929

0.940 (0.404–2.184)

0.885

PNI

0.511 (0.259–1.009)

0.053

0.599 (0.324–1.105)

0.101

0.685 (0.387–1.214)

0.195

pT stage

0.353

0.019

0.009

 T(1)

0.703 (0.119–4.158)

0.698

0.290 (0.021–3.940)

0.352

1.023 (0.162–6.454)

0.981

 T(2)

0.641 (0.091–4.519)

0.655

2.000 (0.134–29.774)

0.615

2.879 (0.312–26.583)

0.351

 T(3)

1.070 (0.144–7.925)

0.947

4.142 (0.269–63.863)

0.309

6.655 (0.700–63.284)

0.099

pN stage

0.590

0.126

0.078

 N(1)

0.921 (0.274–3.101)

0.895

1.439 (0.406–5.106)

0.573

1.312 (0.404–4.262)

0.651

 N(2)

0.589 (0.137–2.523)

0.476

1.120 (0.241–5.205)

0.885

1.025 (0.246–4.270)

0.973

 N(3)

0.847 (0.200–3.586)

0.822

2.117 (0.476–9.409)

0.325

2.022 (0.506–8.075)

0.319

Clinical stage

0.563

0.442

0.299

 Clinical stage (1)

2.258 (0.297–17.150)

0.431

0.608 (0.037–9.896)

0.727

0.492 (0.058–4.183)

0.516

 Clinical stage (2)

4.746 (0.335–67.150)

0.249

1.029 (0.037–28.548)

0.986

0.775 (0.054–11.212)

0.852

 Clinical stage (3)

2.698 (0.095–76.460)

0.561

1.901 (0.060–60.743)

0.716

1.559 (0.092–26.538)

0.759